This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leopold, S. S.
Right arrow Articles by Shott, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leopold, S. S.
Right arrow Articles by Shott, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 84:1619-1623 (2002)
© 2002 The Journal of Bone and Joint Surgery, Inc.


Scientific Article

Increased Frequency of Acute Local Reaction to Intra-Articular Hylan GF-20 (Synvisc) in Patients Receiving More Than One Course of Treatment

Seth S. Leopold, MD, Winston J. Warme, MD , Lieutenant Colonel, Patrick D. Pettis, LVN and Susan Shott, PhD

Investigation performed at the Orthopaedic Surgery Service, William Beaumont Army Medical Center, El Paso, Texas

Seth S. Leopold, MD
Department of Orthopaedics and Sports Medicine,
University of Washington Medical Center, 1959 N.E. Pacific Street, Box 356500, Seattle, WA 98195. E-mail address: leopold{at}u.washington.edu

Lieutenant Colonel Winston J. Warme, MD, Medical Corps, U.S. Army
Patrick D. Pettis, LVN
Orthopaedic Surgery Service, William Beaumont Army Medical Center, 5005 North Piedras Street, 3rd Floor, El Paso, TX 79920

Susan Shott, PhD
Biostatistics Unit, Obstetrics and Gynecology, Rush-Presbyterian-St. Luke's Medical Center, 1653 West Congress Parkway, Chicago, IL 60612

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

The views expressed in this work are those of the authors and do not reflect the official policy of the Department of Defense or the United States Government.

Background: Intra-articular knee injections with hylan GF-20 (Synvisc) have been shown to provide temporary relief of osteoarthritic symptoms. Several studies have suggested that repeated courses of treatment with this product may be administered without an increase in the likelihood of an adverse reaction. The present study was performed to test the hypothesis that the likelihood of a painful reaction to hylan GF-20 does not increase in patients who receive more than one course of treatment.

Methods: The records of all patients who had received more than one course of treatment with hylan GF-20 were compared with a group of patients who had received only one course of treatment during the same fifteen-month period at a single center. The single-course group was prospectively enrolled and followed, as part of an ongoing randomized trial. The two groups were compared with respect to several demographic and clinical parameters as well as with respect to the frequency of painful acute local reactions following injections of hylan GF-20.

Results: Local reactions to hylan GF-20 occurred significantly more often in patients who had received more than one course of treatment than they did in patients who had received only a single course of treatment; the reactions occurred in four (21%) of nineteen patients in the former group and in one (2%) of the forty-two patients in the latter (p = 0.029). All of the reactions were severe enough to cause the patient to seek unscheduled care. Following corticosteroid injection, the reactions abated without apparent sequelae. With the numbers available, no significant differences were detected between the multiple-course and single-course groups in terms of age, gender, body-mass index, or severity or bilaterality of the disease.

Conclusions: The present study suggests that it may be reasonable to counsel patients who have been treated with a course of hylan GF-20 and who desire an additional course that the likelihood of a painful acute local reaction to the medication appears to be increased. Additional study of the frequency of acute local reactions following repeated courses of hylan GF-20 and investigation of the mechanisms of those reactions are warranted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
R. A. Ottaviani, P. Wooley, Z. Song, and D. C. Markel
Inflammatory and Immunological Responses to Hyaluronan Preparations. Study of a Murine Biocompatibility Model
J. Bone Joint Surg. Am., January 1, 2007; 89(1): 148 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Larkin, G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz
CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells
J. Immunol., July 1, 2006; 177(1): 268 - 279.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
K. B. Jones, P. P. Patel, B. R. DeYoung, and J. A. Buckwalter
Viscosupplementation Pseudotumor. A Case Report
J. Bone Joint Surg. Am., May 1, 2005; 87(5): 1113 - 1119.
[Full Text] [PDF]


Home page
JBJSHome page
D. A. Brys, S. S. Leopold, B. B. Redd, W. J. Warme, P. A. Wehrle, P. D. Pettis, and S. Shott
Corticosteroid Compared with Hyaluronic Acid Injections for the Treatment of Osteoarthritis of the Knee * S.S. Leopold, B.B. Redd, W.J. Warme, P.A. Wehrle, P.D. Pettis, and S. Shott reply:
J. Bone Joint Surg. Am., April 1, 2004; 86(4): 874 - 875.
[Full Text] [PDF]


Home page
JBJSHome page
C.-T. Wang, J. Lin, C.-J. Chang, Y.-T. Lin, and S.-M. Hou
Therapeutic Effects of Hyaluronic Acid on Osteoarthritis of the Knee. A Meta-Analysis of Randomized Controlled Trials
J. Bone Joint Surg. Am., March 1, 2004; 86(3): 538 - 545.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. D. Miller
What's New in Sports Medicine
J. Bone Joint Surg. Am., March 1, 2004; 86(3): 653 - 661.
[Full Text] [PDF]


Home page
JBJSHome page
A. H. Morton, P. Shannon, A. L. Chen, P. E. Di Cesare, E. M. Adler, P. Desai, S. S. Leopold, W. J. Warme, P. D. Pettis, and S. Shott
Increased Frequency of Acute Local Reaction to Intra-Articular Hylan G-F 20 (Synvisc) in Patients Receiving More Than One Course of Treatment
J. Bone Joint Surg. Am., October 1, 2003; 85(10): 2050 - 2051.
[Full Text]


Home page
JBJSHome page
A. A. Marino, S. Dunn, D. D. Waddell, A. L. Chen, P. Desai, E. M. Adler, and P. E. Di Cesare
Granulomatous Inflammation After Hylan G-F 20 Viscosupplementation of the Knee
J. Bone Joint Surg. Am., October 1, 2003; 85(10): 2051 - 2053.
[Full Text]


Home page
JBJSHome page
M. A. Mont, G. Etienne, A. L. Chen, P. Desai, E. M. Adler, and P. E. Di Cesare
Sequelae of Hylan G-F 20 Viscosupplementation of the Knee
J. Bone Joint Surg. Am., May 1, 2003; 85(5): 967 - 969.
[Full Text] [PDF]

Letters to the Editor:

Read all Letters to the Editor

A Randomized Comparison of Hylan G-F 20 and Sodium Hyaluronate
Duane C. Heald, et al.
JBJS Online, 30 Jun 2004 [Full text]